HCAR2 and inflammatory bowel disease: These benefices in intestinal inflammatory conditions such as inflammatory bowel diseases (IBD) have been demonstrated by Singh et al. [66] that showed the anti-inflammatory properties of GPR109A signaling in colonic macrophages and dendritic cells, enabling them to induce differentiation of Treg cells and IL-10-producing T cells.